From early failures to prefusion F protein breakthroughs, RSV vaccine development has accelerated, reshaping prevention strategies for infants and older adults.
News-Medical.Net on MSN
Nasal COVID vaccine boost increases IgA responses linked to variant neutralisation
By Hugo Francisco de Souza A novel nasal booster approach may help close the gap between systemic vaccination and infection-blocking mucosal immunity, offering fresh insight into next-generation COVID ...
Scientists have developed a nasal vaccine to protect against bird flu. The corresponding study was published in Cell Reports ...
Since the 1920s, substances containing aluminum called aluminum adjuvants have been used in some vaccines to help boost the body’s immune response. People are exposed to aluminum every day; it is ...
GAITHERSBURG, Md., Sept. 4, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced a milestone payment* from Takeda has been triggered by regulatory approval for Novavax's (NVAX) COVID-19 ...
The induction of respiratory mucosal immunity, characterized by secretory IgA (sIgA) and lung-resident memory T (TRM) cells, is essential for ...
Since it was first detected in the United States in 2014, H5N1 avian influenza, commonly known as bird flu, has jumped from wild birds to farm animals and then to people, causing more than 70 human ...
We demonstrates an innovative strategy for mucosal vaccine design by integrating bacterial N-terminal fatty acylation into a ...
The American parents who are choosing to skip or delay vaccines for their children are more likely to home-school their children, be White and very religious, identify as Republican or be under 35, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results